Compared to FRAX486, IPP-14 induced reduction of viability in two kinds of NF2-impaired cell lines, MDA-MB-231 (human breast cancer cells) and ACHN (human renal cancer cells) (Figure 4E). The gene discussed is IPP; the disease is breast carcinoma.